Merck KGaA injecting €150M into biologics site where it makes immunotherapies

Merck KGaA injecting €150M into biologics site where it makes immunotherapies

Source: 
Fierce Pharma
snippet: 

Just a week after promising a €1 billion investment in its headquarters manufacturing site in Germany, Merck KGaA says it will also invest €150 million into its biologics site in Switzerland.